● Recruiting

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

Condition: Hypoparathyroidism · Sponsor: MBX Biosciences

PhasePhase 3

Planned participants160

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to investigate the efficacy and safety of canvuparatide administered as a once-weekly (QW) treatment to adult study participants with hypoparathyroidism (HypoPT).

This description comes directly from the study's public registry record.

Talk to the study team

Salomon Azoulay, MD · 844-877-4473

Always discuss trial participation with your own doctor first.

Locations (2)

MBX Biosciences Investigational Site	Homestead, Florida, United States	Recruiting
MBX Biosciences Investigational Site	Shavano Park, Texas, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07699471